Inmune Bio Inc (INMB)

07:07 AM

INMune Bio, Inc. (NASDAQ:INMB) Q4 2025 earnings call transcript - MSN

07:07 AM

Apr 05, 2026

Support Test: Whats the RSI of INmune Bio Inc stockWeekly Investment Report & Capital Efficiency Focused Strategies - baoquankhu1.vn

Apr 05, 2026

Apr 04, 2026

INMB.O PE Ratio & Valuation, Is INMB.O Overvalued - Intellectia AI

Apr 04, 2026

Apr 03, 2026

INmune Bio (INMB) price target increased by 33.33% to 7.14 - MSN

Apr 03, 2026

Apr 01, 2026

INmune Bio, Inc. (NASDAQ:INMB) Q4 2025 Earnings Call Transcript - insidermonkey.com

Apr 01, 2026

Apr 01, 2026

INmune Bio (NASDAQ:INMB) Will Have To Spend Its Cash Wisely - Yahoo Finance

Apr 01, 2026

Mar 31, 2026

S P Trends: Whats the profit margin of INmune Bio IncWeekly Trade Report & Weekly Stock Performance Updates - baoquankhu1.vn

Mar 31, 2026

Mar 31, 2026

INmune Bio, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance

Mar 31, 2026

Mar 31, 2026

Earnings Call Summary | INmune Bio(INMB.US) Q4 2025 Earnings Conference - Moomoo

Mar 31, 2026

Mar 31, 2026

Inmune Bio Inc Stock: Recent 2025 Results Highlight Late-Stage Pipeline Progress Amid Cash Runway to - AD HOC NEWS

Mar 31, 2026

Mar 31, 2026

INmune Bio reports $45.9M loss, plans UK regulatory filing By Investing.com - Investing.com South Africa

Mar 31, 2026

Mar 31, 2026

INmune Bio Inc (INMB) Q4 2025 Earnings Call Highlights: Strategic Advances Amid Financial Challenges By GuruFocus - Investing.com Canada

Mar 31, 2026

Mar 30, 2026

INmune Bio Q4 2025 Earnings Call Transcript - MarketBeat

Mar 30, 2026

Mar 30, 2026

INmune Bio Inc (INMB) Q4 2025 Earnings Call Highlights: Strategi - gurufocus.com

Mar 30, 2026

Mar 30, 2026

INmune Bio Inc reports results for the quarter ended September 30Earnings Summary - TradingView

Mar 30, 2026

Mar 30, 2026

Earnings call transcript: INmune Bio highlights CORDStrom progress in Q4 2025 - Investing.com Canada

Mar 30, 2026

Mar 30, 2026

INmune Bio | 10-K: FY2025 Annual Report - Moomoo

Mar 30, 2026

Mar 30, 2026

INMB: CORDStrom nears regulatory filings as cash runway extends to Q1 2027 after $27.5M raised - TradingView

Mar 30, 2026

Mar 30, 2026

Pipeline reset at INmune Bio (NASDAQ: INMB) after CORDStrom gains and XPro setback - stocktitan.net

Mar 30, 2026

Mar 30, 2026

INmune Bio reports $45.9M loss, plans UK regulatory filing - Investing.com

Mar 30, 2026

Mar 30, 2026

INmune Bio Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com

Mar 30, 2026

Mar 30, 2026

Short Squeeze: Will INmune Bio Inc outperform tech stocksTrade Performance Summary & Fast Gain Stock Tips - baoquankhu1.vn

Mar 30, 2026

Mar 29, 2026

INMune Bio FY 2025 earnings preview - MSN

Mar 29, 2026

Mar 29, 2026

INmune Bio Inc. Auditor Raises 'Going Concern' Doubt - marketscreener.com

Mar 29, 2026

Mar 27, 2026

INmune Bio Inc expected to post a loss of 26 cents a shareEarnings Preview - TradingView

Mar 27, 2026

Mar 27, 2026

INMB Technical Analysis | Trend, Signals & Chart Patterns | INMUNE BIO INC (NASDAQ:INMB) - ChartMill

Mar 27, 2026

Mar 24, 2026

INmune Bio (INMB.US) will release its earnings report after the market close on March 30. - Moomoo

Mar 24, 2026

Mar 24, 2026

INmune Bio Inc. to Report Year End 2025 Financial Results and Provide Corporate Update on Monday, March 30th. - The Manila Times

Mar 24, 2026

Mar 24, 2026

INmune Bio Inc. to Report Year End 2025 Financial Results and Provide Corporate Update on ... - Bluefield Daily Telegraph

Mar 24, 2026

Mar 24, 2026

INmune Bio will discuss 2025 results and corporate update March 30 - stocktitan.net

Mar 24, 2026

Mar 22, 2026

Market Moves: Whats the RSI of INmune Bio Inc stock2026 Buyback Activity & Low Drawdown Investment Ideas - baoquankhu1.vn

Mar 22, 2026

Mar 22, 2026

If You Invested $1,000 in Inmune Bio Inc (INMB) - stocktitan.net

Mar 22, 2026

Mar 21, 2026

Block Trades: How does INmune Bio Inc compare to its peersMarket Risk Report & Momentum Based Trading Ideas - baoquankhu1.vn

Mar 21, 2026

Mar 20, 2026

INMB PE Ratio & Valuation, Is INMB Overvalued - Intellectia AI

Mar 20, 2026

Mar 19, 2026

INMB Showcases Advancements in Alzheimer's Treatment at AD/PD 20 - GuruFocus

Mar 19, 2026

Mar 19, 2026

INmune Bio’s MINDFuL trial presented as succesful example in Alzheimer’s - TipRanks

Mar 19, 2026

Mar 19, 2026

INmune Bio’s MINDFuL Trial Featured at AD/PD 2026 Plenary as Successful Example of How to Approach Clinical Trials Targeting Inflammation in Early Alzheimer’s Disease - The Manila Times

Mar 19, 2026

Mar 19, 2026

Alzheimer’s trial gets plenary spotlight as blood markers guide treatment - Stock Titan

Mar 19, 2026

Mar 18, 2026

INMB stock rises pre-market – what did the FDA say about its Alzheimer’s trial? - MSN

Mar 18, 2026

Mar 18, 2026

Rally Mode: Whats the profit margin of INmune Bio IncTrade Exit Report & Free Expert Verified Stock Movement Alerts - baoquankhu1.vn

Mar 18, 2026

Mar 18, 2026

Market Outlook: Is INmune Bio Inc stock undervalued right nowPortfolio Risk Summary & Accurate Buy Signal Notifications - baoquankhu1.vn

Mar 18, 2026

Mar 17, 2026

Setup Watch: How liquid is INmune Bio Inc stockTrade Entry Report & AI Forecast for Swing Trade Picks - baoquankhu1.vn

Mar 17, 2026

Mar 16, 2026

Will INmune Bio Inc benefit from geopolitical trends2026 Momentum & Free Community Supported Trade Ideas - baoquankhu1.vn

Mar 16, 2026

Mar 16, 2026

INmune Bio Inc Stock (ISIN: US45764T1060) Faces Analyst Hold Consensus Amid $8 Price Target - AD HOC NEWS

Mar 16, 2026

Mar 15, 2026

INmune Bio Receives $8 Consensus Price Target from Analysts - National Today

Mar 15, 2026

Mar 13, 2026

INmune Bio (NASDAQ:INMB) Stock Rating Upgraded by Lucid Cap Mkts - Defense World

Mar 13, 2026

Mar 12, 2026

Lucid Capital Markets upgrades INmune Bio (INMB) - MSN

Mar 12, 2026

Mar 11, 2026

INMB Stock Receives Major Upgrade from Lucid Capital Markets | I - GuruFocus

Mar 11, 2026

Mar 11, 2026

Lucid Capital Markets upgrades INmune Bio stock rating on RDEB therapy - Investing.com Australia

Mar 11, 2026

Mar 11, 2026

Lucid Capital Markets upgrades INmune Bio stock rating on RDEB therapy By Investing.com - Investing.com India

Mar 11, 2026

Mar 08, 2026

INmune Bio, Inc. (NASDAQ:INMB) Given Average Recommendation of “Reduce” by Analysts - Defense World

Mar 08, 2026